Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Neuland Laboratories

Neuland Laboratories Share Price

Neuland Laboratories (INR)16250.7606.7   (3.9%)

Exchange ScripsBSE524558NSENEULANDLABISININE794A01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Neuland Laboratories Performance

Market performance
Open price15640
High16524.9
Volumes102164
Prev Close16250.7
Low15355.1
Closing date2024-10-16
Historical performance
1 Year High16524.95
3 Year High16524.95
5 Year High16524.95
1 Year Low3611.10
3 Year Low967.00
5 Year Low245.75

Neuland Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
20149
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
66.89
Dividend Yield
Dividend Yield
0.01 %

Neuland Laboratories Investment Returns

1 Year
305.4%
3 Years
758%
5 Years
3108.4%
10 Years
3294.2%

Neuland Laboratories Technicals

IndicatorsValueSignal
5-DMA14579.44Bullish
10-DMA13181.38Bullish
20-DMA12893.48Bullish
50-DMA12437.73Bullish
100-DMA9949.03Bullish
200-DMA8202.09Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1111111111
Foreign Investors22222
Domestic Investors99999
Public Investors2906628605277122681325212
Government11111

Neuland Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1259721161
Operating Profit4751281614471629
Interest140131135179
Depreciation597528490397
Profit Before Tax401421578221053
Consolidated Net Profit30011635638806
Adjusted EPS2341275063

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital129129129129
Total Reserves12698981282767736
Minority Interest------------
Total Non-Current Liabilities1222146717981698
Total Liabilities18326157981383513248
Capital Work in Progress459406205173
Total Assets18326157981383513248

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities261223726041894
Cash Flow from Investing Activities-1497-615-955-844
Cash Flow from Financing Activitie-693-1358377-1137
Net Cash Inflow / Outflow42239926-87
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 66.89.
  • 3Y Stock Price CAGR of the stock is 108.2.
  • The stock has a beta of 0.5.
  • In the last financial year, the company had an EBITDA of ₹4751 Million.
  • The company generated revenue of ₹15586 Million in the previous financial year.

Neuland Laboratories

16250.7606.7   (3.9%)

Investment Amount: ₹ 401590
Current Value: ₹ 1625070
Performence: 304.7%
P/L: ₹ 1223480
Top Gainers
SymbolChange%
PREMIERPOL332.18(20%)
VAISHALI21.97(20%)
ANGELONE3236(18%)
AJMERA830.7(16%)
MOTILALOFS962.05(12%)
Top Losers
SymbolChange%
HAVISHA2.64(-8%)
SOMATEX45.58(-7%)
SHANTI17.37(-7%)
WEL1491.9(-6%)
ORIENTLTD114.7(-6%)
DELTAMAGNT98.78(-6%)
DBCORP333.35(-6%)
AKSHAR1.29(-6%)
Similar stocks

RPG Life Sciences

▲ 24.2

2818.8

September 16 - October 16

Vaishali Pharma

▲ 20.2

21.97

September 16 - October 16

Medicamen Biotech

▲ 17.4

531.4

September 16 - October 16

Strides Pharma Scien

▲ 15.6

1630.95

September 16 - October 16

Ipca Laboratories

▲ 15.5

1655.65

September 16 - October 16

Unichem Lab

▲ 13.9

727.1

September 16 - October 16

Astrazeneca Pharma I

▲ 12

7649.75

September 16 - October 16

Jagsonpal Pharma

▲ 11.4

449.4

September 16 - October 16

Announcing Stock of the Month!

Stock of the Month
Stock of the Month